z-logo
open-access-imgOpen Access
Could dupilumab put an end to the therapeutic draught in prurigo nodularis?
Author(s) -
Gil Yosipovitch,
Susanne Kammerer
Publication year - 2022
Language(s) - English
Resource type - Conference proceedings
DOI - 10.55788/b8270ac0
Subject(s) - dupilumab , prurigo nodularis , dermatology , medicine , computer science , atopic dermatitis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here